VI Partners — 2015 Investments

1 investments dated 2015 · listed companies and verified rows first · show all

JenaValvejenavalve.comJul 2015 · $62.5M

JenaValve develops transcatheter aortic valve replacement systems to treat severe aortic regurgitation and aortic stenosis.

Digital HealthHealthtechMedical DevicesIrvine, US

Hans Figulla(Director)Markus FerrariVictoria Carr-Brendel(Executive Officer, Director)David Drachman(Executive Officer, Director)John Kilcoynein

Board seatArnd Kaltofen· per SEC Form D

Co-investorsAndera Partners Bain Capital Life Sciences Rosetta Capital Ltd.Atlas Venture Gimv Innovatus Capital Partners +5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.